The combination of Helicobacter pylori- and cytotoxin-associated gene-A seropositivity in relation to the risk of myocardial infarction in middle-aged Japanese: The Japan Public Health Center-based study

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 67-72

  Ikeda, Ai ^a,b   Iso, Hiroyasu ^c   Sasazuki, Shizuka ^a   Inoue, Manami ^a   Tsugane, Shoichiro ^a  

^a NATIONAL CANCER CENTER   (Japan)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CagA; Follow up studies; Helicobacter pylori; Myocardial infarction; Stroke

Indexed keywords

CAGA PROTEIN; IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; JAPANESE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS;

CAGA; FOLLOW-UP STUDIES; HELICOBACTER PYLORI; MYOCARDIAL INFARCTION; STROKE;

ADULT; AGE FACTORS; AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; JAPAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; STROKE;

EID: 84881628983     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.06.013     Document Type: Article

References (32)

1. Ross R. Atherosclerosis-an inflammatory disease. NEngl J Med 1999, 14(340):115-126.
2. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease is there a link?. Lancet 1997, 350:430-436.
3. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997, 96:4095-4103.
4. Pober J.S. Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology. Am J Pathol 1988, 133:426-433.
5. Wick G., Perschinka H., Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999, 138:S444-S449.
6. Fan X.G., Yakoob J., Chua A., Fan X.J., Keeling P.W. Helicobacter pylori-induced lipid peroxidation in peripheral blood lymphocytes. APMIS 1995, 103:316-319.
7. Stemme S., Faber B., Holm J., Wiklund O., Witztum J.L., Hansson G.K. Tlymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci 1995, 92:3893-3897.
8. Crabtree J.E., Covacci A., Farmery S.M., Xiang Z., Tompkins D.S., Perry S., et al. Helicobacter pylori-induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. JClin Pathol 1995, 48:41-45.
9. Cover T.L., Glupczynski Y., Lage A.P., Burette A., Tummuru M.K., Perez-Perez G.I., et al. Serologic detection of infection with CagA+ Helicobacter pylori strains. JClin Microbiol 1995, 33:1496-1500.
10. Blaser M.J. Intrastrain differences in Helicobacter pylori: a key question in mucosal damage?. Ann Med 1995, 27:559-563.
11. Pasceri V., Patti G., Cammarota G., Pristipino C., Richichi G., Sciascio G.D. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J 2006, 151:1215-1222.
12. Franceschi F., Niccoli G., Ferrante G., Gasbarrini A., Baldi A., Candelli M., et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009, 202:535-542.
13. World Gastroenterology Organization World Gastroenterology Organization global guidelines: Helicobacter pylori in developing countries 2010, World Gastroenterology Organization.
14. Censini S., Lange C., Xiang Z., Crabtree J.E., Ghiara P., Borodovsky M., et al. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996, 93:14648-14653.
15. Akopyants N.S., Clifton S.W., Kersulyte D., Crabtree J.E., Youree B.E., Reece C.A., et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998, 28:37-53.
16. Maeda S., Yoshida H., Ikenoue T., Ogura K., Kanai F., Kato N., et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 1999, 44:336-341.
17. Iso H. Changes in coronary heart disease risk among Japanese. Circulation 2008, 118:2725-2729.
18. Tsugane S., Sobue T. Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. JEpidemiol 2001, 11:S24-S29.
19. Tunstall-Pedoe H., Kuulasmaa K., Amouyel P., Arveiler D., Rajakangas A.M., Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994, 90:583-612.
20. Walker A.E., Robins M., Weinfeld F.D. The National Survey of Stroke. Clinical findings. Stroke 1981, 12:I13-I44.
21. Rothman K.J., Greenland S. Measures of effect and association. Modern epidemiology 1998, 47-64. Lippincott Williams & Wilkins, Philadelphia, Pa.
22. Sasazuki S., Inoue M., Iwasaki M., Otani T., Yamamoto S., Ikeda S., et al. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2006, 15:1341-1347.
23. Danesh J., Wong Y., Ward M., Muir J. Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegaloviruspopulation-based study of coronary heart disease. Heart 1999, 81:245-247.
24. O'Donnell C.J., Levy D. Weighing the evidence for infection as a risk factor for coronary heart disease. Curr Cardiol Rep 2000, 4:280-287.
25. Haider A.W., Wilson P.W., Larson M.G., Evans J.C., Michelson E.L., Wolf P.A., et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. JAm Coll Cardiol 2002, 40:1408-1413.
26. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ischaemic heart disease negative result from a large, prospective study. BMJ 1997, 315:1199-1201.
27. Strandberg T.E., Tilvis R.S., Vuoristo M., Lindroos M., Kosunen T.U. Prospective study of Helicobacter pylori seropositivity and cardiovascular diseases in a general elderly population. BMJ 1997, 314:1317-1318.
28. Folsom A.R., Nieto F.J., Sorlie P., Chambless L.E., Graham D.Y. Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) study investigators. Circulation 1998, 98:845-850.
29. Strachan D.P., Mendall M.A., Carrington D., Butland B.K., Yarnell J.W., Sweetnam P.M., et al. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation 1998, 98:1286-1290.
30. Franceschi F., Sepulveda A.R., Gasbarrini A., Pola P., Silveri N.G., Gasbarrini G., et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002, 106:430-434.
31. Iso H., Noda H., Ikeda A., Yamagishi K., Iwasaki M., Inoue M., et al. The impact of C-reactive protein on risk of stroke, stroke subtypes and ischemic heart disease in middle-aged Japanese: the Japan Public Health Center-Based Study. JAtheroscler Thromb 2012, 19:756-766.
32. Iwasaki M., Yamamoto S., Otani T., Inoue M., Hanaoka T., Sobue T., Japan Public Health Center-based Prospective Study Group, et al. Generalizability of relative risk estimates from a well-defined population to a general population. Eur J Epidemiol 2006, 21:253-262.